Edition:
United Kingdom

Accuray Inc (ARAY.OQ)

ARAY.OQ on NASDAQ Stock Exchange Global Select Market

4.90USD
8 Dec 2017
Change (% chg)

$-0.25 (-4.85%)
Prev Close
$5.15
Open
$5.10
Day's High
$5.10
Day's Low
$4.85
Volume
134,909
Avg. Vol
144,867
52-wk High
$6.00
52-wk Low
$3.60

Select another date:

Tue, Oct 24 2017

BRIEF-Accuray Inc reports Q1 loss per share $0.11

* Accuray generated $55.6 million in first quarter gross orders; revenue increased 5 percent year over year

BRIEF-European Court Of Appeal rejects Varian's attempt to reverse customer purchase of Accuray TomoTherapy system

* European Court Of Appeal rejects Varian's attempt to reverse customer purchase of Accuray TomoTherapy system

BRIEF-Accuray reports Q4 loss per share of $0.06

* Accuray reports fourth quarter and fiscal 2017 financial results

BRIEF-Accuray issues $85 mln principal amount of 3.75 pct convertible senior notes

* Accuray Inc says ‍on August 7, issued $85 million aggregate principal amount of its 3.75% convertible senior notes due 2022 - sec filing​ Source text: (http://bit.ly/2umHI40) Further company coverage:

BRIEF-Accuray says receives 510(k) clearance for IDMS data management system upgrade for Tomotherapy system

* Says receives 510(k) clearance for IDMS data management system upgrade for Tomotherapy system Source text for Eikon: Further company coverage:

BRIEF-Accuray enhances capital structure through convertible debt transactions

* Accuray Inc - company has also entered into agreements to privately sell $32 million aggregate principal amount of new notes for cash to certain other investors

BRIEF-Neuro Spinal Hospital in Dubai to buy Accuray Cyberknife and Radixact Systems

* Accuray Inc - ‍deal was entered into backlog during Accuray's fourth fiscal quarter which ended June 30, 2017​

BRIEF-Accuray Inc signs new revolving loan agreement

* Closed a new $52 million senior secured revolving loan facility with Midcap Financial Trust Source text for Eikon: Further company coverage:

Select another date: